140 related articles for article (PubMed ID: 17726064)
21. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
22. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.
Liu L; McBride KM; Reich NC
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8150-5. PubMed ID: 15919823
[TBL] [Abstract][Full Text] [Related]
23. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.
Ogata Y; Osaki T; Naka T; Iwahori K; Furukawa M; Nagatomo I; Kijima T; Kumagai T; Yoshida M; Tachibana I; Kawase I
Neoplasia; 2006 Oct; 8(10):817-25. PubMed ID: 17032498
[TBL] [Abstract][Full Text] [Related]
25. Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking.
Martincuks A; Fahrenkamp D; Haan S; Herrmann A; Küster A; Müller-Newen G
Cell Signal; 2016 Aug; 28(8):810-25. PubMed ID: 27040695
[TBL] [Abstract][Full Text] [Related]
26. The role of STATs in transcriptional control and their impact on cellular function.
Bromberg J; Darnell JE
Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
[TBL] [Abstract][Full Text] [Related]
27. Suppression of STAT3 NH
Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
[TBL] [Abstract][Full Text] [Related]
28. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
[TBL] [Abstract][Full Text] [Related]
29. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
30. Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain.
Mohr A; Fahrenkamp D; Rinis N; Müller-Newen G
Cell Commun Signal; 2013 Nov; 11():83. PubMed ID: 24192293
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective inhibition of STAT3 tyrosine 705 phosphorylation.
Fei Y; Zhang X; Wang X; Sun Y; He J; Liu X; Song Z; Li L; Qiu L; Qian Z; Zhou S; Liu X; Zhang H; Wang X
J Nat Med; 2024 Mar; 78(2):285-295. PubMed ID: 38082192
[TBL] [Abstract][Full Text] [Related]
32. Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patients.
Stärkel P; Saeger CD; Leclercq I; Horsmans Y
Lab Invest; 2007 Feb; 87(2):173-81. PubMed ID: 17318196
[TBL] [Abstract][Full Text] [Related]
33. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
Ray S; Boldogh I; Brasier AR
Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
[TBL] [Abstract][Full Text] [Related]
34. STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line.
Isobe A; Takeda T; Sakata M; Yamamoto T; Minekawa R; Hayashi M; Auernhammer CJ; Tasaka K; Murata Y
Placenta; 2006 Aug; 27(8):912-8. PubMed ID: 16300827
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of STAT3 activation in the liver of FXR knockout mice.
Li G; Zhu Y; Tawfik O; Kong B; Williams JA; Zhan L; Kassel KM; Luyendyk JP; Wang L; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(11):G829-37. PubMed ID: 24091600
[TBL] [Abstract][Full Text] [Related]
36. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte.
Liu Z; Gan L; Zhou Z; Jin W; Sun C
Immunobiology; 2015 Aug; 220(8):947-53. PubMed ID: 25720636
[TBL] [Abstract][Full Text] [Related]
37. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
38. SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase.
Miao T; Wu D; Zhang Y; Bo X; Xiao F; Zhang X; Magoulas C; Subang MC; Wang P; Richardson PM
Mol Cell Neurosci; 2008 Feb; 37(2):367-75. PubMed ID: 18055217
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation.
Dimitriadis E; Stoikos C; Tan YL; Salamonsen LA
Endocrinology; 2006 Aug; 147(8):3809-17. PubMed ID: 16709613
[TBL] [Abstract][Full Text] [Related]
40. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus.
Xu L; Kang Y; Cöl S; Massagué J
Mol Cell; 2002 Aug; 10(2):271-82. PubMed ID: 12191473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
